Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Á¡¸·ÇÏ MidazolamÀÇ º´¿ëÅõ¿© ½Ã BIS ºÐ¼®À» ÀÌ¿ëÇÑ ÁøÁ¤ Æò°¡

Sedation evaluation using bis index assessment with and without the added submucosal midazolam

´ëÇѼҾÆÄ¡°úÇÐȸÁö 2007³â 34±Ç 1È£ p.91 ~ 98
ÀÌ¿µÀº, ¹Ú¹Ì°æ, ±è¼Ò¿µ, ±èÀ±Èñ, Á¤»óÇõ, ¹é±¤¿ì,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌ¿µÀº ( Lee Young-Eun ) - ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ÀÓ»óÄ¡ÀÇÇдëÇпø ¼Ò¾ÆÄ¡°úÇб³½Ç
¹Ú¹Ì°æ ( Park Mi-Kyung ) - ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ÀÓ»óÄ¡ÀÇÇдëÇпø ¼Ò¾ÆÄ¡°úÇб³½Ç
±è¼Ò¿µ ( Kim So-Young ) - ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ÀÓ»óÄ¡ÀÇÇдëÇпø ¼Ò¾ÆÄ¡°úÇб³½Ç
±èÀ±Èñ ( Kim Yoon-Hee ) - ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ÀÓ»óÄ¡ÀÇÇдëÇпø ¼Ò¾ÆÄ¡°úÇб³½Ç
Á¤»óÇõ ( Jung Sang-Hyuk ) - ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ÀÓ»óÄ¡ÀÇÇдëÇпø ¼Ò¾ÆÄ¡°úÇб³½Ç
¹é±¤¿ì ( Baek Kwang-Woo ) - ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¿¹¹æÀÇÇб³½Ç

Abstract

Chloral hydrate(CH)¿Í HydroxyzineÀÇ °æ±¸ º¹¿ëÀ» ÀÌ¿ëÇÑ ÁøÁ¤°ú MidazolamÀ» Á¡¸·ÇÏ ÁÖ»ç·Î Ãß°¡ Åõ¿©ÇÑ ÁøÁ¤À» Bispectral(BIS) index¸¦ ÀÌ¿ëÇÏ¿© µÎ ÁøÁ¤¹ýÀÇ ÁøÁ¤ ±íÀÌÀÇ Â÷À̸¦ ºñ±³ Æò°¡ÇÏ°íÀÚ ÇÏ¿´´Ù.

¸ðµç ȯ¾Æ´Â 2¼¼-6¼¼ »çÀÌÀÇ ¹Ì±¹ ¸¶Ãë°úÇÐȸ ½ÅüÆò°¡ µî±Þ IÀÇ °Ç°­ÇÑ È¯¾Æ·Î ÁøÁ¤ ¿ä¹ýÀÌ ¿ä±¸µÇ¾úÀ¸¸ç ±¹¼Ò¸¶Ãë¿Í ÃÖ¼Ò 2°³ ÀÌ»óÀÇ Ä¡¾Æ¿¡ ´ëÇÑ ¼öº¹ Ä¡·á°¡ Ä¡·á¿¡ Æ÷ÇԵǾú´Ù. ¹«ÀÛÀ§ ¹æ¹ýÀ¸·Î ȯ¾Æ¸¦ CH(60mg/kg)¿Í Hydroxyzine(1mg/kg)À» º¹¿ëÇÏ´Â ±º°ú CH(60mg/kg)¿Í Hydroxyzine(1mg/kg)À» º¹¿ëÇÏ°í Á¡¸·ÇÏ ÁÖ»ç·Î Midazolam(0.1mg/kg)À» Ãß°¡ Åõ¿©ÇÏ´Â ±ºÀ¸·Î ³ª´©¾ú´Ù. ÁøÁ¤ ¿ä¹ý µ¿¾È Nitrous Oxide´Â µÎ ±º ¸ðµÎ 50%·Î À¯Áö ÇÏ¿´´Ù. ȯ¾Æ Çൿ Æò°¡´Â ³ìÈ­µÈ ºñµð¿À Å×ÀÌÇÁ¸¦ º¸¸ç ¸Å 2ºÐ¸¶´Ù Behavior scaleÀ» ÀÌ¿ëÇÏ¿© quiet(Q), crying(C), movement(M), or struggling(S)À¸·Î ÃøÁ¤ÇÏ¿´´Ù. µÎ ±ºÀÇ ÁøÁ¤ ±íÀÌ ºñ±³ Æò°¡¸¦ À§ÇØ Ä¡·á°¡ ½ÃÀÛµÈ ½ÃÁ¡ºÎÅÍ 40ºÐ µ¿¾È 2ºÐ °£°ÝÀ¸·Î ÃøÁ¤ ÇÑ Pulse rate(PR), Saturation percentage of 0_(2)(SpO_(2)), brhavior scale°ú ¸Å 2ºÐ ´ÜÀ§·Î °è»êµÈ Æò±Õ BIS index¸¦ t-test¿Í Levene¡¯s test¸¦ ÀÌ¿ëÇÏ¿© ºÐ¼®ÇÏ¿´´Ù.

µÎ ±ºÀÇ Æò±Õ BIS index¿Í BIS indexÀÇ ºÐÆ÷´Â À¯ÀÇÇÒ ¸¸ÇÑ Â÷À̸¦ º¸¿´´Ù(P<0.001). Á¡¸·ÇÏ ÁÖ»ç·Î MidazolamÀ» Ãß°¡ Åõ¿©ÇÑ ±º¿¡¼­ Æò±Õ BIS index°¡ ´õ ³·Àº °ªÀ» °¡Áö¸ç Ç¥ÁØ ÆíÂ÷°¡ ÀÛ¾Ò´Ù. PR¿Í SpO_(2)´Â µÎ ±×·ì ¸ðµÎ Á¤»ó ¹üÀ§³»ÀÇ °ªÀ» º¸¿´´Ù. Á¡¸·ÇÏ Áֻ縦 ÀÌ¿ëÇÑ MidazolamÀÇ Ãß°¡ Åõ¿©´Â ¾ÈÀü¼ºÀ» Å©°Ô ħÇØÇÏÁö ¾Ê´Â ¹üÀ§ ³»¿¡¼­ ÁøÁ¤ ±íÀ̸¦ ±í°Ô ÇØÁÖ¸ç ¾ÈÁ¤ÀûÀÎ ÁøÁ¤À» ÀÌ·ç°Ô ÇÔÀ¸·Î½á º¸´Ù ¹Ù¶÷Á÷ÇÑ ÁøÁ¤À» À¯µµÇØ ÁÙ ¼ö ÀÖ´Â °ÍÀ¸·Î »ç·áµÈ´Ù.

The aim of this study was to examine the difference of the depth of sedation using the Bispectral index assessment with and without the added submucosal Midazolam to oral Chloral hydrate and Hydroxyzine for pediatric patients.

Twenty seven sedation cases were performed in this study. Selection criteria included good health(ASA I), 2 to 6 years of age, the need for sedation to receive dental treatment including anesthesia, and restorative procedure over at least two teeth. Patients were randomly classified into one group taking oral Chloral hydrate(60 mg/kg) and Hydroxyzine(1 mg/kg) and the other group recieving Chloral hydrate(60 mg/kg),

Hydroxyzine(1 mg/kg) and submucosal Midazolam(0.1 mg/kg). Nitrous Oxide(50%) was used for both group during sedation. Patients were monitored using a pulse oximeter and a Bispectral monitor. A behavior scale was rated as quiet(Q), crying(C), movement(M), or struggling(S) every 2 minutes watching a recorded videotape.

Analysis showed a significant difference in mean Bispectral index and SD during sedation across two groups(P<0.001). The group of patients injected with submucosal Midazolam in addition to oral Chloral hydrate and Hydroxyzine showed a lower mean Bispectral index and a narrower SD. PR and Sp02 for both groups remained within the normal values.

Submucosal Midazolam improved the sedation quality by deepening sedation depth without compromising safety and enabled the sedation pattern to be kept more stable.

Å°¿öµå

ÁøÁ¤; Á¡¸·ÇÏ ÁÖ»ç;
midazolam; bispectal index; sedation; submucosal midazolam; bispectral index

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI